1. Антонова Е. И., Ачилов А. Б., Фирсова Н. В., Викторов Д. А., Балацюк Е. В. Разработка xMAP-протокола ASPE детекции мутаций генов BRAF и MITF в образцах поверхностно-распространяющейся меланомы кожи // Научный медицинский вестник Югры. 2024. Т. 42, № 4. С. 53-62. DOI: 10.25017/2306-1367-2024-42-53-62
2. Снарская Е. С., Олисова О. Ю., Васильева К. Д. Амеланоцитарная узловая меланома кожи у пациентки с отягощенным семейным анамнезом // Российский журнал кожных и венерических болезней. 2022. Т. 25, № 4. C. 261-268. DOI: 10.17816/dv111571
3. Aebischer V., Abu-Ghazaleh A., Metzler G., Riedl L., Garbe C., Flatz L., Eigentler T., Forchhammer S. Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stage // Pigment Cell Melanoma Res. 2023. Vol. 36, no. 6. P. 512-521. DOI: 10.1111/pcmr.13114
4. Colombino M., Casula M., Paliogiannis P., Manca A., Sini M. C., Pisano M., Santeufemia D. A., Cossu A., Palmieri G. Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond // Crit. Rev. Oncol. Hematol. 2024. Vol. 201. P. 104435. 10.1016/j.critrevonc. 2024.104435. DOI: 10.1016/j.critrevonc.2024.104435
5. Drexler K., Zenderowski V., Schreieder L., Koschitzki K., Karrer S., Berneburg M., Haferkamp S., Niebel D. Subtypes of melanomas associated with different degrees of actinic elastosis in conventional histology, irrespective of age and body site, suggesting chronic ultraviolet light exposure as driver for lentigo maligna melanoma and nodular melanoma // Cancers (Basel). 2023. Vol. 16, no. 1. Art. 1. DOI: 10.3390/cancers16010001
6. Druskovich C., Kelley J., Aubrey J., Palladino L., Wright G. P. A review of melanoma subtypes: genetic and treatment considerations // J. Surg. Oncol. 2025. Vol. 131, no. 3. P. 356-364. DOI: 10.1002/jso.27953
7. Frischhut N., Zelger B., Andre F., Zelger B. G. The spectrum of melanocytic nevi and their clinical implications // J. Dtsch. Dermatol. Ges. 2022. Vol. 20, no. 4. Р. 483-504. DOI: 10.1111/ddg.14776
8. Gronbeck C., Kerr P. E. Nodular melanoma // Clin. Dermatol. 2025. Vol. 43, no. 1. P. 64-70. 10.1016/ j.clindermatol.2025.01.015. DOI: 10.1016/j.clindermatol.2025.01.015
9. Guzniczak A., Sosnowska-Sienkiewicz P., Szydlowski J., Kurzawa P., Januszkiewicz-Lewandowska D. Gene mutation-negative malignant melanoma in a prepubertal patient: a clinical and molecular case report // Genes. 2025. Vol. 16, no. 8. Art. 937. DOI: 10.3390/genes16080937
10. Huang C., Lau T. W.-S., Smoller B. R. Diagnosing cutaneous melanocytic tumors in the molecular era: updates and review of literature // Dermatopathology (Basel). 2024. Vol. 11, no. 1. P. 26-51. DOI: 10.3390/dermatopathology11010005
11. Jiang C., Jain N. P., Stewart C. L. Amelanotic melanoma: clinical presentation, diagnosis, and management // Clin. Dermatol. 2025. Vol. 43, no. 1. P. 10-15. DOI: 10.1016/j.clindermatol.2025.01.009
12. Manganelli M., Stabile G., Scharf C., Brunetti A. P., Paolino G., Giuffrida R., Bigotto G. D., Damiano G., Mercuri S. R., Sallustio F., Mangano E., Bordoni R., De Nardi P., Guida G., Foti C., Argenziano G., Longo C., Pellacani G., Rizzo N., Russo V., Guida S., Rongioletti F. Skin photodamage and melanomagenesis: A comprehensive review // Cancers. 2025. Vol. 17, no. 11. Art. 1784. DOI: 10.3390/cancers17111784
13. Mirek J., Bal W., Olbryt M. Melanoma genomics - will we go beyond BRAF in clinics? // J. Cancer Res. Clin. Oncol. 2024. Vol. 150, no. 9. Art. 433. 10.1007/ s00432-024-05957-2. DOI: 10.1007/s00432-024-05957-2
14. Paller C. J., Tukachinsky H., Maertens A., Decker B., Sampson J. R., Cheadle J. P., Antonarakis E. S. Pancancer interrogation of MUTYH variants reveals biallelic inactivation and defective base excision repair across a spectrum of solid tumors // JCO Precis. Oncol. 2024. Vol. 8, no. 8. e2300251. DOI: 10.1200/PO.23.00251
15. Prkacin I., Sami ja I., Filipovic N., Vucic M., Vucic M., Ferara N., Situm M. Frequency of BRAF mutations in dysplastic nevi, lentigo maligna, and melanoma In Situ // J. Clin. Med. 2024. Vol. 13, no. 16. Art. 4799. DOI: 10.3390/jcm13164799 EDN: FTMJHK
16. Singh N., Dunlop K. L. A., Woolley N., Wills Vashishtha T., Damian D. L., Vuong K., Cust A. E., Smit A. K. A review of skin cancer primary prevention activities in primary care settings // Public Health Res. Pract. 2024. Vol. 34(2). Art. 34012401. DOI: 10.17061/phrp34012401
17. Spaccarelli N., Drozdowski R., Peters M. S., Grant-Kels J. M. Dysplastic nevus part II: Molecular/genetic profiles and management // J. Am. Acad. Dermatol. 2023. Vol. 88, no. 1. P. 13-20. DOI: 10.1016/j.jaad.2022.05.071
18. Sukniam K., Manaise H. K., Popp K., Popp R., Gabriel E. Role of surgery in metastatic melanoma and review of melanoma molecular characteristics // Cells. 2024. Vol. 13, no. 6. Art. 465. DOI: 10.3390/cells13060465
19. Wallingford C. K., Maas E. J., Howard A., DeBortoli E., Bhanja D., Lee K., Mothershaw A., Jagirdar K., Willett R., Betz-Stablein B., Sturm R. A., Soyer H. P., McInerney-Leo A. M. MITF E318K: A rare homozygous case with multiple primary melanoma // Pigment. Cell Melanoma Res. 2024. Vol. 37, no. 1. P. 68-73. DOI: 10.1111/pcmr.13122
20. Zhang S., Xiao X., Yi Y., Wang X., Zhu L., Shen Y., Lin D., Wu C. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets // Signal Transduct. Target. Ther. 2024. Vol. 1. Art. 149.